Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5274 of 6351
-
New remote program aims to ease chemo burden for pancreatic cancer patients
Symptom relief CompletedThe purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition and supportive care for participants living with pancreatic cancer who are receiving …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New remote nutrition program aims to help cancer patients during treatment
Symptom relief CompletedThe purpose of the study is to assess the feasibility and patient satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastroesophageal cancer who are receiving chemot…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New biomarker may predict which cancer drugs work best
Knowledge-focused CompletedThe primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict response of patients to specific therapies or therapeutic combinations using isolated tumor cells from various specimen for…
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Gene therapy for rare metabolic disease passes early safety check
Disease control OngoingThis is a non-interventional long-term follow-up study of patients who have participated in LogicBio studies for the treatment of MMA and received hLB-001
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New pregnancy registry aims to uncover risks of MS drug ZEPOSIA for mothers and babies
Knowledge-focused Recruiting nowThe purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed tr…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New spanish screening tool could help catch substance abuse early
Knowledge-focused CompletedThe goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:15 UTC
-
Spinal cord injury study reveals body's hidden stress during routine catheterization
Knowledge-focused CompletedThis is a prospective, randomised study investigating the physical and psychological experience of intermittent catheterization in adult individuals following spinal cord injury (SCI).
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New insulin timing trick may tame blood sugar after pizza and burgers
Disease control CompletedThis study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained from this study may provide a method to allow for the proper administration of insulin over an exten…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New heart scan could help ER doctors spot artery blockages faster
Diagnosis Stopped earlyThis is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronar…
Sponsor: HeartFlow, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New program aims to ease dementia care decisions for african american families
Knowledge-focused By invitation onlyThe purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases o…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Estrogen cream studied for Post-Birth injury recovery
Symptom relief Stopped earlyObstetric anal sphincter injuries (OASIS) cause significant morbidity and are well known risk factors for sexual dysfunction, urinary and anal incontinence. Postpartum and breastfeeding are relative hypoestrogenic states with risk factors for dyspareunia and vaginal atrophy. Estr…
Phase 4 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Shocking and lasering: new combo therapy tested for paralysis
Knowledge-focused CompletedThe goal of this Spinal Cord Injury (SCI) Open-Label Clinical Trial is to test the safety and feasibility of the intervention. The study aims to answer whether implementing this intervention on inpatients at a specialized rehabilitation hospital is possible. All participants will…
Sponsor: Spaulding Rehabilitation Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Hip infection study aims to improve treatment choices
Knowledge-focused Recruiting nowProsthetic Joint Infection (PJI) of a Total Hip Replacement (THR) is a disastrous complication of an otherwise extremely successful surgical procedure. It is associated with a burdensome treatment for the patient, significant challenges for the medical team and high costs for soc…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New study tests heat treatment for painful uterine condition
Knowledge-focused CompletedTo observe the effects of radiofrequency ablation on adenomyosis through the pathological analysis of treated tissue that has been removed during planned hysterectomy.
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Whey protein boosts teen soccer stars?
Symptom relief CompletedThe overall aim of this project is to compare protein supplementation on performance, recovery, and body composition changes in adolescent soccer players between the whey protein and the control group in response to the 10-12-week intervention.
Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Sculptra safety checked beyond the face
Symptom relief CompletedMulti-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New test could predict dangerous blood pressure drops in dialysis patients
Diagnosis CompletedHemodynamic instability episodes are a frequent complication of renal replacement therapies in critically ill patients, and their incidence is associated with worse survival. Hypovolemia, identified by the existence of biventricular preload dependence, is responsible for one epis…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Scientists track rare genetic hearing loss over time
Knowledge-focused Recruiting nowThis is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Sponsor: Akouos, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Experimental eye drug targets genetic blindness
Disease control CompletedAn open-label Phase II clinical trial, 8 (eight) subjects with retinitis pigmentosa due to rhodopsin mutations (including P23H) will be identified and treated with serial intravitreal injections of ADX-2191 in the worse seeing eye. Ocular structure and function will be evaluated.
Phase 2 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New biologic LP-003 takes first step in human safety trial
Knowledge-focused CompletedThe purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP…
Phase 1 • Sponsor: Longbio Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC